Arizona 2024 2024 Regular Session

Arizona House Bill HB2582 Comm Sub / Analysis

Filed 02/21/2024

                      	HB 2582 
Initials AG/KT 	Page 1 	House Engrossed 
 
ARIZONA HOUSE OF REPRESENTATIVES 
Fifty-sixth Legislature 
Second Regular Session 
House: HHS DP 7-3-0-0 
 
HB 2582: pharmacists; collaborative practice agreements 
Sponsor: Representative Gillette, LD 30 
House Engrossed 
Overview 
Includes physician assistants and certified nurse midwifes in the statutory definition of a 
provider who may enter into a collaborative practice agreement with a pharmacist. 
History 
A collaborative practice agreement is an agreement between a pharmacist and a provider that 
outlines the drug therapy and disease management services, including initiating, monitoring 
and modifying prescription drug and laboratory test orders that are authorized by the 
provider and delegated to the pharmacist for the purpose of drug therapy management or 
disease management based on the pharmacist's skills or training. Initiating, monitoring and 
modifying does not include a pharmacist's selection of drug products that are not prescribed 
by the provider unless the selection of specific drug products is authorized by the 
collaborative practice agreement.  
These collaborative practice agreements may be between one or more pharmacists and one 
or more providers. A provider can be a licensed medical doctor, osteopathic physician or 
registered nurse practitioner.  
A collaborative practice agreement must: 
1) outline the duties related to drug therapy and disease management that the provider 
is delegating to the pharmacist to perform; 
2) specify, at a minimum, the conditions to be managed by the pharmacist through 
disease management and drug therapy management, the circumstances for which the 
pharmacist must notify the provider and any documentation or recordkeeping 
requirements; and 
3) specify that the pharmacist must follow the written drug therapy and disease 
management guidelines provided by the provider and may provide drug therapy and 
disease management services only pursuant to those guidelines.  
The Arizona State Board of Pharmacy, the Arizona Medical Board, the Arizona Board of 
Osteopathic Examiners in Medicine and Surgery and the Arizona State Board of Nursing 
may adopt rules relating to collaborative practice agreements (A.R.S. § 32-1970). 
Provisions 
1. Adds physician assistants and certified nurse midwives to the list of providers who may 
enter into a collaborative practice agreement with a pharmacist. (Sec. 1) 
2. Makes a technical change. (Sec. 1) 
 
☐ Prop 105 (45 votes)     ☐ Prop 108 (40 votes)      ☐ Emergency (40 votes) ☐ Fiscal Note